Inducible super-enhancers are organized based on canonical signal-specific transcription factor binding elements

Nucleic Acids Research

Volumn 45, Issue 7, 2017, Pages 3693-3706

  Bojcsuk, Dóra ^a   Nagy, Gergely ^a   Balint, Balint L ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CELL NUCLEUS RECEPTOR; DEOXYRIBONUCLEASE; DIMER; E1A ASSOCIATED P300 PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INTERFERON REGULATORY FACTOR; NUCLEAR FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; VITAMIN D RECEPTOR; FOXA1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR AP 2;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BONE MARROW DERIVED MACROPHAGE; CONTROLLED STUDY; CYTOPLASM; ESTROGEN RESPONSIVE ELEMENT; GENE TARGETING; HIGH THROUGHPUT SEQUENCING; HORMONAL REGULATION; HUMAN; MCF-7 CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; ANIMAL; CELL CULTURE; ENHANCER REGION; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; BINDING SITES; CELL LINE, TUMOR; CELLS, CULTURED; ENHANCER ELEMENTS, GENETIC; ESTROGEN RECEPTOR ALPHA; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; MCF-7 CELLS; MICE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS;

EID: 85019057713     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw1283     Document Type: Article

References (56)

1. Davies, E. and Hiscox, S. (2011) New therapeutic approaches in breast cancer. Maturitas, 68, 121-128.
2. Shang, Y, Hu, X., DiRenzo, J., Lazar, M.A. and Brown, M. (2000) Cofactor dynamics and suffciency in estrogen receptor-regulated transcription. Cell, 103, 843-852.
3. Klein-Hitpass, L., Schorpp, M., Wagner, U. and Ryffel, G.U. (1986) An estrogen-responsive element derived from the 5' fanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell, 46, 1053-1061.
4. Kumar, V and Chambon, P. (1988) The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell, 55, 145-156.
5. Soule, H.D., Vazguez, J., Long, A., Albert, S. and Brennan, M. (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51, 1409-1416.
6. Levenson, A.S. and Jordan, V.C. (1997) MCF-7: the frst hormone-responsive breast cancer cell line. Cancer Res., 57, 3071-3078.
7. Vega, V.B., Lin, C.-Y, Lai, K.S., Kong, S.L., Xie, M., Su, X., Teh, H.F., Thomsen, J.S., Yeo, A.L., Sung, W.K. et al (2006) Multiplatform genome-wide identifcation and modeling of functional human estrogen receptor binding sites. Genome Biol, 7, R82.
8. Joseph, R., Orlov, YL., Huss, M., Sun, W., Kong, S.L., Ukil, L., Pan, YF., Li, G., Lim, M., Thomsen, J.S. et al. (2010) Integrative model of genomic factors for determining binding site selection by estrogen receptor-a. Mol Syst. Biol, 6, 456.
9. Vierstra, J., Rynes, E., Sandstrom, R., Zhang, M., Canfeld, T., Hansen, R.S., Stehling-Sun, S., Sabo, P.J., Byron, R., Humbert, R. et al. (2014) Mouse regulatory DNA landscapes reveal global principles of cis-regulatory evolution. Science, 346, 1007-1012.
10. Tan, S.K., Lin, Z.H., Chang, C.W., Varang, V, Chng, K.R., Pan, YF., Yong, E.L., Sung, W.K. and Cheung, E. (2011) AP-2-y regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription. EMBO J., 30, 2569-2581.
11. Caizzi, L., Ferrero, G., Cutrupi, S., Cordero, F., Ballare, C, Miano, V., Reineri, S., Ricci, L., Friard, O., Testori, A. et al. (2014) Genome-wide activity of unliganded estrogen receptor-a in breast cancer cells. Proc Natl. Acad. Sci. U.S.A., 111, 4892-4897.
12. Carroll, J.S. and Brown, M. (2006) Estrogen receptor target gene: an evolving concept. Mol. Endocrinol., 20, 1707-1714.
13. Lupien, M., Eeckhoute, J., Meyer, C.A., Wang, Q., Zhang, Y, Li, W., Carroll, J.S., Liu, X.S. and Brown, M. (2008) FoxA1 translates epigenetic signatures into enhancer-driven lineage-specifc transcription. Cell, 132, 958-970.
14. Robinson, J.L.L. and Carroll, J.S. (2012) FoxA1 is a key mediator of hormonal response in breast and prostate cancer. Front. Endocrinol (Lausanne), 3, 68.
15. Carroll, J.S., Liu, X.S., Brodsky, A.S., Li, W., Meyer, C.A., Szary, A.J., Eeckhoute, J., Shao, W., Hestermann, E. V, Geistlinger, T.R. et al (2005) Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell, 122, 33-43.
16. Loven, J., Hoke, H.A., Lin, C.Y, Lau, A., Orlando, D.A., Vakoc, C.R., Bradner, J.E., Lee, T.I. and Young, R.A. (2013) Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell, 153, 320-334.
17. Whyte, W.A., Orlando, D.A., Hnisz, D., Abraham, B.J., Lin, C.Y, Kagey, M.H., Rahl, P.B., Lee, T.I. and Young, R.A. (2013) Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell, 153, 307-319.
18. Tolani, B., Gopalakrishnan, R., Punj, V., Matta, H. and Chaudhary, P.M. (2014) Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors. Oncogene, 33, 2928-2937.
19. Mansour, M.R., Abraham, B.J., Anders, L., Berezovskaya, A., Gutierrez, A., Durbin, A.D., Etchin, J., Lawton, L., Sallan, S.E., Silverman, L.B. et al. (2014) Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science, 346, 1373-1377.
20. Hnisz, D., Abraham, B.J., Lee, TI., Lau, A., Saint-Andre, V, Sigova, A.A., Hoke, H.A. and Young, R.A. (2013) Super-enhancers in the control of cell identity and disease. Cell, 155, 934-947.
21. Heinz, S., Benner, C, Spann, N., Bertolino, E., Lin, YC, Laslo, P., Cheng, J.X., Murre, C, Singh, H. and Glass, CK. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell, 38, 576-589.
22. Brown, J.D., Lin, CY, Duan, Q., Griffn, G, Federation, A.J., Paranal, R.M., Bair, S., Newton, G, Lichtman, A.H., Kung, A.L. et al. (2014) NF-KB directs dynamic super enhancer formation in infammation and atherogenesis. Mol. Cell, 56, 219-231.
23. Di Micco, R., Fontanals-Cirera, B., Low, V, Ntziachristos, P, Yuen, S.K., Lovell, CD., Dolgalev, I., Yonekubo, Y, Zhang, G, Rusinova, E. et al. (2014) Control of embryonic stem cell identity by BRD4-dependent transcriptional elongation of super-enhancer-associatedpluripotency genes. Cell Rep., 9, 234-247.
24. Sengupta, D., Kannan, A., Kern, M., Moreno, M.A., Vural, E., Stack, B., Suen, J.Y, Tackett, A.J. and Gao, L. (2015) Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma. Epigenetics, 10, 460-466.
25. Park, S.W., Li, G, Lin, Y-P, Barrero, M.J., Ge, K., Roeder, R.G and Wei, L.-N. (2005) Thyroid hormone-induced juxtaposition of regulatory elements/factors and chromatin remodeling of Crabp1 dependent on MED1/TRAP220. Mol. Cell, 19, 643-653.
26. Kagey, M.H., Newman, J.J., Bilodeau, S., Zhan, Y, Orlando, D.A., van Berkum, N.L., Ebmeier, CC, Goossens, J., Rahl, PB., Levine, S.S. et al. (2010) Mediator and cohesin connect gene expression and chromatin architecture. Nature, 467, 430-435.
27. Malik, S. and Roeder, R.G (2010) The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat. Rev. Genet., 11, 761-772.
28. Yin, J. and Wang, G. (2014) The Mediator complex: a master coordinator of transcription and cell lineage development. Development, 141, 977-987.
29. Tsai, C-J. and Nussinov, R. (2011) Gene-specifc transcription activation via long-range allosteric shape-shifting. Biochem. J., 439, 15-25.
30. Schmidt, D., Schwalie, PC, Ross-Innes, CS., Hurtado, A., Brown, GD., Carroll, J.S., Flicek, P and Odom, D.T (2010) A CTCF-independent role for cohesin in tissue-specifc transcription. Genome Res., 20, 578-588.
31. Welboren, W.-J., van Driel, M.A., Janssen-Megens, E.M., van Heeringen, S.J., Sweep, FC, Span, PN. and Stunnenberg, H.G (2009) ChIP-Seq of ERalpha and RNA polymerase II defnes genes differentially responding to ligands. EMBO J., 28, 1418-1428.
32. Takayama, K., Suzuki, T, Tsutsumi, S., Fujimura, T, Urano, T, Takahashi, S., Homma, Y, Aburatani, H. and Inoue, S. (2015) RUNX1, an androgen-and EZH2-regulated gene, has differential roles in AR-dependent and-independent prostate cancer. Oncotarget, 6, 2263-2276.
33. Ostuni, R., Piccolo, V, Barozzi, I., Polletti, S., Termanini, A., Bonifacio, S., Curina, A., Prosperini, E., Ghisletti, S. and Natoli, G (2013) Latent enhancers activated by stimulation in differentiated cells. Cell, 152, 157-171.
34. Lee, S.M., Riley, E.M., Meyer, M.B., Benkusky, N.A., Plum, L.A., DeLuca, H.F and Pike, J.W. (2015) 1, 25-Dihydroxyvitamin D3 Controls a Cohort of Vitamin D Receptor Target Genes in the Proximal Intestine That Is Enriched for Calcium-regulating Components. J. Biol. Chem., 290, 18199-18215.
35. Edgar, R., Domrachev, M. and Lash, A.E. (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res., 30, 207-210.
36. Fletcher, M.N.C, Castro, M.A.A., Wang, X., de Santiago, I., O'Reilly, M., Chin, S.-F, Rueda, O.M., Caldas, C., Ponder, B.A.J., Markowetz, F et al. (2013) Master regulators of FGFR2 signalling and breast cancer risk. Nat. Commun., 4, 2464.
37. Li, W., Notani, D., Ma, Q., Tanasa, B., Nunez, E., Chen, A.Y, Merkurjev, D., Zhang, J., Ohgi, K., Song, X. et al. (2013) Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature, 498, 516-520.
38. Joseph, R., Orlov, YL., Huss, M., Sun, W., Kong, S.L., Ukil, L., Pan, YF, Li, G, Lim, M., Thomsen, J.S. et al. (2010) Integrative model of genomic factors for determining binding site selection by estrogen receptor-a;. Mol. Syst. Biol, 6, 456.
39. Hu, M., Yu, J., Taylor, J.M.G, Chinnaiyan, A.M. and Qin, Z.S. (2010) On the detection and refnement of transcription factor binding sites using ChIP-Seq data. Nucleic Acids Res., 38, 2154-2167.
40. Welboren, W.-J., van Driel, M.A., Janssen-Megens, E.M., van Heeringen, S.J., Sweep, FC, Span, PN. and Stunnenberg, H.G (2009) ChIP-Seq of ERalpha and RNA polymerase II defnes genes differentially responding to ligands. EMBO J., 28, 1418-1428.
41. Brunelle, M., Nordell Markovits, A., Rodrigue, S., Lupien, M., Jacques, P-E. and Gevry, N. (2015) The histone variant H2A.Z is an important regulator of enhancer activity. Nucleic Acids Res., 43, 9742-9756.
42. He, H.H., Meyer, CA., Chen, M.W., Jordan, VC, Brown, M. and Liu, X.S. (2012) Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Res., 22, 1015-1025.
43. Liu, Z., Merkurjev, D, Yang, F, Li, W., Oh, S., Friedman, M.J., Song, X., Zhang, F, Ma, Q., Ohgi, K.A. et al. (2014) Enhancer activation requires trans-recruitment of a mega transcription factor complex. Cell, 159, 358-373.
44. Franco, H.L., Nagari, A. and Kraus, W.L. (2015) TNFa signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome. Mol. Cell, 58, 21-34.
45. Swinstead, E.E., Miranda, TB., Paakinaho, V., Baek, S., Goldstein, I., Hawkins, M., Karpova, T.S., Ball, D., Mazza, D, Lavis, L.D et al. (2016) Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions. Cell, 165, 593-605.
46. Hurtado, A., Holmes, K.A., Ross-Innes, CS., Schmidt, D and Carroll, J.S. (2011) FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet., 43, 27-33.
47. Guertin, M.J., Zhang, X., Coonrod, S.A. and Hager, GL. (2014) Transient estrogen receptor binding and p300 redistribution support a squelching mechanism for estradiol-repressed genes. Mol. Endocrinol., 28, 1522-1533.
48. Barta, E. (2011) Command line analysis of ChIP-seq results. EMBnet.journal, 17, 13-17.
49. Zhang, Y, Liu, T, Meyer, CA., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum, C, Myers, R.M., Brown, M., Li, W. et al. (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol, 9, R137.
50. Dunham, I., Kundaje, A., Aldred, S.F, Collins, PJ., Davis, CA., Doyle, F, Epstein, CB., Frietze, S., Harrow, J., Kaul, R. et al. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57-74.
51. Quinlan, A.R. and Hall, I.M. (2010) BEDTools: a fexible suite of utilities for comparing genomic features. Bioinformatics, 26, 841-842.
52. Saldanha, A.J. (2004) Java Treeview-extensible visualization of microarray data. Bioinformatics, 20, 3246-3248.
53. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H. and Nakatani, Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87, 953-959.
54. Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J.-P., Barsyte-Lovejoy, D., Felletar, I., Volkmer, R., Müller, S., Pawson, T. et al. (2012) Histone recognition and large-scale structural analysis of the human bromodomain family. Cell, 149, 214-231.
55. Siersbæk, R., Baek, S., Rabiee, A., Nielsen, R., Traynor, S., Clark, N., Sandelin, A., Jensen, O.N., Sung, M.-H., Hager, G.L. et al. (2014) Molecular architecture of transcription factor hotspots in early adipogenesis. 7, 1434-1442.
56. Siersbæk, R., Rabiee, A., Nielsen, R., Sidoli, S., Traynor, S., Loft, A., La Cour Poulsen, L., Rogowska-Wrzesinska, A., Jensen, O.N. and Mandrup, S. (2014) Transcription factor cooperativity in early adipogenic hotspots and super-enhancers. Cell Rep., 7, 1443-1455.